BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 4, 2025
Home
»
Topics
»
Regulatory
» NMPA
NMPA
RSS
CFDA grants approval for clinical trials of fadanafil
Dec. 16, 2016
CFDA accepts CStone Pharmaceuticals' IND for anti-PD-L1 monoclonal antibody
Oct. 21, 2016
BeiGene cleared to conduct clinical trials of BGB-A317 in China
Sep. 12, 2016
Chinese clinical trial authorization for TaiGen's furaprevir
Aug. 19, 2016
BioNano Genomics and Berry Genomics to codevelop next-generation mapping system
Aug. 18, 2016
Cervarix approved in China
July 18, 2016
CFDA approves Roche's CINtec PLUS Cytology test
March 9, 2016
3SBio obtains IND clearance in China for PEG-irinotecan
March 7, 2016
Tapros approved for open-angle glaucoma and ocular hypertension in China
Aug. 26, 2015
CFDA approves phase I/II/III clinical trials of pirotinib
Aug. 14, 2015
Previous
1
2
…
45
46
47
48
49
50
51
52
53
Next